United States Meningitis Vaccine Market Report 2016

October 2016 | 120 pages | ID: UB84AB466DCEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Meningitis Vaccine

Revenue, means the sales value of Meningitis Vaccine

This report studies sales (consumption) of Meningitis Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• GlaxoSmithKline
• Baxter International
• Sanofi Pasteur
• Merck
• Novartis
• Pfizer
• Hualan
• Zhejiang Tianyuan
• Beijing Tiantan Biological

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Meningitis A+C
• Meningitis ACWY135
• Meningitis B

Split by applications, this report focuses on sales, market share and growth rate of Meningitis Vaccine in each application, can be divided into

• Medical care
• Healthy
• Hospital

Contents

United States Meningitis Vaccine Market Report 2016

1 MENINGITIS VACCINE OVERVIEW

1.1 Product Overview and Scope of Meningitis Vaccine
1.2 Classification of Meningitis Vaccine
  1.2.1 Meningitis A+C
  1.2.2 Meningitis ACWY135
  1.2.3 Meningitis B
1.3 Application of Meningitis Vaccine
  1.3.1 Medical care
  1.3.2 Healthy
  1.3.3 Hospital
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Meningitis Vaccine (2011-2021)
  1.4.1 United States Meningitis Vaccine Sales and Growth Rate (2011-2021)
  1.4.2 United States Meningitis Vaccine Revenue and Growth Rate (2011-2021)

2 UNITED STATES MENINGITIS VACCINE COMPETITION BY MANUFACTURERS

2.1 United States Meningitis Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Meningitis Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Meningitis Vaccine Average Price by Manufactures (2015 and 2016)
2.4 Meningitis Vaccine Market Competitive Situation and Trends
  2.4.1 Meningitis Vaccine Market Concentration Rate
  2.4.2 Meningitis Vaccine Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES MENINGITIS VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Meningitis Vaccine Sales and Market Share by Type (2011-2016)
3.2 United States Meningitis Vaccine Revenue and Market Share by Type (2011-2016)
3.3 United States Meningitis Vaccine Price by Type (2011-2016)
3.4 United States Meningitis Vaccine Sales Growth Rate by Type (2011-2016)

4 UNITED STATES MENINGITIS VACCINE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Meningitis Vaccine Sales and Market Share by Application (2011-2016)
4.2 United States Meningitis Vaccine Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES MENINGITIS VACCINE MANUFACTURERS PROFILES/ANALYSIS

5.1 GlaxoSmithKline
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Meningitis Vaccine Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 GlaxoSmithKline Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Baxter International
  5.2.2 Meningitis Vaccine Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Baxter International Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Sanofi Pasteur
  5.3.2 Meningitis Vaccine Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Sanofi Pasteur Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Merck
  5.4.2 Meningitis Vaccine Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Merck Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Novartis
  5.5.2 Meningitis Vaccine Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Novartis Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Pfizer
  5.6.2 Meningitis Vaccine Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Pfizer Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Hualan
  5.7.2 Meningitis Vaccine Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Hualan Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Zhejiang Tianyuan
  5.8.2 Meningitis Vaccine Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Zhejiang Tianyuan Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Beijing Tiantan Biological
  5.9.2 Meningitis Vaccine Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Beijing Tiantan Biological Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview

6 MENINGITIS VACCINE MANUFACTURING COST ANALYSIS

6.1 Meningitis Vaccine Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Meningitis Vaccine

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Meningitis Vaccine Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Meningitis Vaccine Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES MENINGITIS VACCINE MARKET FORECAST (2016-2021)

10.1 United States Meningitis Vaccine Sales, Revenue Forecast (2016-2021)
10.2 United States Meningitis Vaccine Sales Forecast by Type (2016-2021)
10.3 United States Meningitis Vaccine Sales Forecast by Application (2016-2021)
10.4 Meningitis Vaccine Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Meningitis Vaccine
Table Classification of Meningitis Vaccine
Figure United States Sales Market Share of Meningitis Vaccine by Type in 2015
Figure Meningitis A+C Picture
Figure Meningitis ACWY135 Picture
Figure Meningitis B Picture
Table Application of Meningitis Vaccine
Figure United States Sales Market Share of Meningitis Vaccine by Application in 2015
Figure Medical care Examples
Figure Healthy Examples
Figure Hospital Examples
Figure United States Meningitis Vaccine Sales and Growth Rate (2011-2021)
Figure United States Meningitis Vaccine Revenue and Growth Rate (2011-2021)
Table United States Meningitis Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States Meningitis Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Meningitis Vaccine Sales Share by Manufacturers
Figure 2016 Meningitis Vaccine Sales Share by Manufacturers
Table United States Meningitis Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States Meningitis Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Meningitis Vaccine Revenue Share by Manufacturers
Table 2016 United States Meningitis Vaccine Revenue Share by Manufacturers
Table United States Market Meningitis Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Meningitis Vaccine Average Price of Key Manufacturers in 2015
Figure Meningitis Vaccine Market Share of Top 3 Manufacturers
Figure Meningitis Vaccine Market Share of Top 5 Manufacturers
Table United States Meningitis Vaccine Sales by Type (2011-2016)
Table United States Meningitis Vaccine Sales Share by Type (2011-2016)
Figure United States Meningitis Vaccine Sales Market Share by Type in 2015
Table United States Meningitis Vaccine Revenue and Market Share by Type (2011-2016)
Table United States Meningitis Vaccine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Meningitis Vaccine by Type (2011-2016)
Table United States Meningitis Vaccine Price by Type (2011-2016)
Figure United States Meningitis Vaccine Sales Growth Rate by Type (2011-2016)
Table United States Meningitis Vaccine Sales by Application (2011-2016)
Table United States Meningitis Vaccine Sales Market Share by Application (2011-2016)
Figure United States Meningitis Vaccine Sales Market Share by Application in 2015
Table United States Meningitis Vaccine Sales Growth Rate by Application (2011-2016)
Figure United States Meningitis Vaccine Sales Growth Rate by Application (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Meningitis Vaccine Sales Market Share (2011-2016)
Table Baxter International Basic Information List
Table Baxter International Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Baxter International Meningitis Vaccine Sales Market Share (2011-2016)
Table Sanofi Pasteur Basic Information List
Table Sanofi Pasteur Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Pasteur Meningitis Vaccine Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Meningitis Vaccine Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Meningitis Vaccine Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Meningitis Vaccine Sales Market Share (2011-2016)
Table Hualan Basic Information List
Table Hualan Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hualan Meningitis Vaccine Sales Market Share (2011-2016)
Table Zhejiang Tianyuan Basic Information List
Table Zhejiang Tianyuan Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zhejiang Tianyuan Meningitis Vaccine Sales Market Share (2011-2016)
Table Beijing Tiantan Biological Basic Information List
Table Beijing Tiantan Biological Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Beijing Tiantan Biological Meningitis Vaccine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Meningitis Vaccine
Figure Manufacturing Process Analysis of Meningitis Vaccine
Figure Meningitis Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Meningitis Vaccine Major Manufacturers in 2015
Table Major Buyers of Meningitis Vaccine
Table Distributors/Traders List
Figure United States Meningitis Vaccine Production and Growth Rate Forecast (2016-2021)
Figure United States Meningitis Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table United States Meningitis Vaccine Production Forecast by Type (2016-2021)
Table United States Meningitis Vaccine Consumption Forecast by Application (2016-2021)